TY  - JOUR
TI  - Short-term Results of The Add-on Lacosamide Therapyin Patients with Drug-resistant Focal Onset Seizures
AB  - Objectives: Lacosamide (LCM) is a new generation amino acid drug that is used in patients with drug-resistant epilepsy, which increases the slow inactivation of voltage-dependent sodium channels. In this study, the short-term results of patients with drug-resistant epilepsy who received add-on LCM therapy were evaluated. Methods: Patients who were at least 16 years old and had focal onset seizures for a minimum period of 1 year were retrospectively assessed. Those who had uncontrolled seizures, despite the use of two appropriate antiepileptic drugs at an effective dose for at least six months, were included in the study. Forty-five eligible patients (11 females, 34 males) underwent further analysis. LCM therapy doses, change in seizure fre-quency, number of seizures before and after LCM therapy, and the effect of LCM add-on therapy on seizures were analyzed. Results: The mean age of the included 45 patients (11 females, 34 males) was 31.42 (16–56) years. Twenty-six of 45 (57.8%) patients under add-on therapy showed a decrease of 50% or more. It was observed that the seizure frequency decreased to a median of 2 (IQR: 0.5–5), which was statistically significant (p<0.001). The dose was not correlated with the seizure decrease ratio (p=0.216). The decrease in seizure frequency was similar in patients with LCM add-on treatment as the second or third drug, when compared with patients using LCM as the fourth or fifth drug (p=0.231).Conclusion: It was observed that LCM add-on therapy significantly decreased seizure frequency, similar to the current literature. On the con-trary, the dose effect or earlier add-on therapy did not show a significant effect on seizure frequency. LCM should be considered as a successful treatment option in patients with drug-resistant focal onset seizures.
AU  - EREN, FULYA
AU  - Ceyhan Dirican, Ayten
AU  - Baybas, Sevim
AU  - Atakli, Hayrunisa Dilek
AU  - tekin, betül
AU  - Gul, Gunay
DO  - 10.14744/epilepsi.2020.59244
PY  - 2021
JO  - Epilepsi
VL  - 27
IS  - 1
SN  - 1300-7157
SP  - 47
EP  - 51
DB  - TRDizin
UR  - http://search/yayin/detay/418120
ER  -